Recent reports from the Congressional Research Service concerning China include these (all pdf).
“Hong Kong: Ten Years After the Handover,” June 29, 2007.
“China’s Economic Conditions,” updated July 13, 2007.
“Taiwan: Major U.S. Arms Sales Since 1990,” updated July 12, 2007.
“China-U.S. Trade Issues,” updated July 11, 2007.
“China-U.S. Relations: Current Issues and Implications for U.S. Policy,” updated June 14, 2007.
“Food and Agricultural Imports from China,” updated July 17, 2007.
“The Southwest Pacific: U.S. Interests and China’s Growing Influence,” July 6, 2007.
“China’s Currency: A Summary of the Economic Issues,” updated July 11, 2007.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.